Biogen Inc. (BIIB)

Biogen Inc. is listed in the United States. Sector: Healthcare. Industry: Drug Manufacturers - General.

Biogen Inc. (BIIB): research close 250.79 USD on 2026-11-17. 52-week range 164.42 to 254.87 USD. Sector: Healthcare. Historical research data, not advice.

Dated company evidence

FactFigureAs of
Historical research close250.79 USD2026-11-17
Previous research close251.65 USD2026-11-16
Change between the two dated research closes-0.34%2026-11-16 – 2026-11-17
Market capitalisation37.18 billion USD2026-11-16
52-week range of the research close164.42 – 254.87 USD2025-11-18 – 2026-11-17
One-year change in the research close52.29%2025-11-17 – 2026-11-17
Average daily turnover (20 sessions)300.17 million USD2026-11-17

Source: us_closes_adjusted · US · research close

Historical research prices; adjustments vary by market. This is not a live quote or a forecast.

Continue your company research

Members can compare available company evidence and explicitly save BIIB to a watchlist. A company is saved only after Save is pressed for it.

Free membership opens nine research tools, starting with the Hotlist: the stocks drawing unusual turnover each session.

Nine member offerings. Free. No card.

Join free

Research, not advice.

Research on this page's measures

Glossary: AVWAP · Date of Control · Beta · Loading · Market cap · Cost of equity · Implied rate

Most-traded US companies

Full list of most-traded US companies